NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced the nomination of Roger M. Perlmutter, M.D., Ph.D., to stand for election to the company’s board of directors at its June 8, 2021 annual meeting of stockholders.
April 28, 2021
· 8 min read